Have researchers at the University of Bern created a sensitivity based hydrogel for hand transplant patients? Reports indicate that the injectable gel based solution will be used to coat the medication, allowing the drug to travel through the bloodstream at the same pace, but sustaining the medication until it arrives to the target area. The hydrogel will help to deliver a longer lasting drug, directly to the area. This will help benefit patients who are post surgery, and especially patients that have immune systems that are at risk.
The self-assembled nanofibrous hydrogels, which have been used to treat rheumatoid arthritis, react to an enzyme that concentrates in areas of inflammation and split to release the immunosuppressant. by loading the drugs into hydrogels, higher concentrations can last much longer without causing an initial overload.
Will other transplant surgeries benefit from hydrogel in the future? Will hydrogels be the answer to hypersensitive drug delivery methods?